{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:46:25Z","timestamp":1787010385764,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Direct"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Living kidney donors (LKDs) experience reduction in kidney function, however serum phosphate (sPi) levels are lower compared to patients with chronic kidney disease matched for reduced kidney function. Mineral metabolism adaptations that occur in LKDs have not been adequately investigated. To evaluate the effect of nephrectomy on markers of mineral metabolism in LKDs compared to healthy volunteers (HV) over 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Mineral parameters were evaluated in twenty-one adult LKDs and twenty HVs. Parameters included sPi, intact parathyroid hormone, fibroblast growth factor-23 (FGF23), soluble Klotho (sKl) and urinary phosphate, measured prior to donation (T\n                      <jats:sub>0<\/jats:sub>\n                      ), 1 month (T\n                      <jats:sub>1<\/jats:sub>\n                      ), 6 months (T\n                      <jats:sub>6<\/jats:sub>\n                      ) and 12 months (T\n                      <jats:sub>12<\/jats:sub>\n                      ) post-kidney donation. Statistical analyses were conducted on normalized variables and changes were assessed using 2-way analysis of variance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mean ages of LKDs and HVs were 54.1 \u00b1 14.7 and 52.6 \u00b1 8.0 years, respectively. There were no baseline clinical or biochemical differences between LKDs and HVs. In LKDs at T\n                      <jats:sub>1<\/jats:sub>\n                      , serum creatinine increased (from 75 \u00b1 12 to 114 \u00b1 22 \u03bcmol\/L), FGF23 increased (52 \u00b1 15 to 70 \u00b1 19 pg\/mL) and sKl decreased (564 [469-662] to 424 [375-523] pg\/mL), all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      less than 0.001. Changes were sustained at T\n                      <jats:sub>12<\/jats:sub>\n                      . After donation, LKDs consistently demonstrated lower sPi compared with T\n                      <jats:sub>0<\/jats:sub>\n                      , with the maximal sPi change at T\n                      <jats:sub>6<\/jats:sub>\n                      (\u22120.19 mmol\/L difference,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Other markers of mineral metabolism were unchanged in LKDs. There were no mineral differences in HVs over 12 months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Prospective evaluation of mineral metabolism parameters in LKDs provides valuable insight into compensatory mechanisms after reduction in kidney function. Further reduction of sPi at T\n                      <jats:sub>6<\/jats:sub>\n                      despite early alterations in FGF23 and sKl suggest adaptation of mineral metabolism continues long-term in LKDs.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000000660","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T16:14:01Z","timestamp":1490717641000},"page":"e150","source":"Crossref","is-referenced-by-count":7,"title":["Changes in Markers of Mineral Metabolism After Living Kidney Donation"],"prefix":"10.1097","volume":"3","author":[{"given":"Sven-Jean","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim D.","family":"Hewitson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel D.","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,4]]},"reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","year":"2011","journal-title":"Kidney Int"},{"key":"bib2-20231002","first-page":"794","article-title":"Plasma Klotho and mortality risk in older community-dwelling adults","volume":"66","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.krcp.2015.12.006","article-title":"Assessment of the relationship between serum soluble Klotho and carotid intima-media thickness and left ventricular dysfunction in hemodialysis patients","volume":"35","year":"2016","journal-title":"Kidney Res Clin Pract"},{"issue":"Pt 2","key":"bib4-20231002","first-page":"203","article-title":"Fibroblast growth factor 23","volume":"51","year":"2014","journal-title":"Ann Clin Biochem"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","year":"2011","journal-title":"JAMA"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.bone.2012.02.634","article-title":"Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis","volume":"50","year":"2012","journal-title":"Bone"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/sj.ki.5001819","article-title":"Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression","volume":"70","year":"2006","journal-title":"Kidney Int"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7326\/0003-4819-145-3-200608010-00006","article-title":"Meta-analysis: risk for hypertension in living kidney donors","volume":"145","year":"2006","journal-title":"Ann Intern Med"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.2013.285141","article-title":"Risk of end-stage renal disease following live kidney donation","volume":"311","year":"2014","journal-title":"JAMA"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2013.460","article-title":"Long-term risks for kidney donors","volume":"86","year":"2014","journal-title":"Kidney Int"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/00007890-199710150-00007","article-title":"Kidney donors live longer","volume":"64","year":"1997","journal-title":"Transplantation"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2010.237","article-title":"Perioperative mortality and long-term survival following live kidney donation","volume":"303","year":"2010","journal-title":"JAMA"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"e1203","DOI":"10.1136\/bmj.e1203","article-title":"Cardiovascular disease in kidney donors: matched cohort study","volume":"344","year":"2012","journal-title":"BMJ"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.transproceed.2012.07.150","article-title":"The impact of nephrectomy and renal transplantation on serum levels of soluble Klotho protein","volume":"45","year":"2013","journal-title":"Transplant Proc"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bone.2014.01.020","article-title":"Acute and long term mineral metabolism adaptation in living kidney donors: a prospective study","volume":"62","year":"2014","journal-title":"Bone"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","year":"2009","journal-title":"Ann Intern Med"},{"key":"bib19-20231002","first-page":"309","article-title":"Nomogram for derivation of renal threshold phosphate concentration","volume":"2","year":"1975","journal-title":"Lancet"},{"key":"bib20-20231002","first-page":"158","article-title":"Tests of phosphate reabsorption","volume":"2","year":"1973","journal-title":"Lancet"},{"issue":"Pt 1","key":"bib21-20231002","first-page":"79","article-title":"Calculation of renal tubular reabsorption of phosphate: the algorithm performs better than the nomogram","volume":"37","year":"2000","journal-title":"Ann Clin Biochem"},{"key":"bib22-20231002","first-page":"1","article-title":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1093\/ndt\/gfq288","article-title":"Fibroblast growth factor-23 and mineral metabolism after unilateral nephrectomy","volume":"25","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.kint.2016.05.012","article-title":"Abnormalities in biomarkers of mineral and bone metabolism in kidney donors","volume":"90","year":"2016","journal-title":"Kidney Int"},{"key":"bib25-20231002","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.ajkd.2011.09.019","article-title":"Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation","volume":"59","year":"2012","journal-title":"Am J Kidney Dis"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01845228-201704000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T03:07:23Z","timestamp":1696216043000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01845228-201704000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000000660","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}